Drawing for ONE MEDICAL

USPTO serial 97512902

ONE MEDICAL

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
Examiner
SIRIGNANO, EMMA MARIE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with ONE MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $749*

Plus Government fees of $900

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James F. Struthers

James F. Struthers Richard Law Group5910 N Central Expy Ste 325Dallas, TX 75206United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software to permit users to identify, request, and receive pharmacy products; downloadable software for prescription ordering, fulfillment, delivery, and patient record management; downloadable software that provides retail and ordering services for pharmaceutical preparations, sanitary preparations, medical supplies, personal care products, and healthcare products; downloadable computer software for providing consumer product information for the purpose of selection of pharmaceuticals and over the counter medicationsACTIVE
035Advertising services; business management; business administration; providing office functions; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; pharmaceutical services, namely, ordering, fulfillment, and management services for prescriptions; distributorship services in the field of prescription drugs for telemedicine providers; supplying prescription drugs to telemedicine participants who are health plan participants for funding organizations; retail store services, online retail store services, retail store and online retail store services all featuring pharmaceutical preparations, sanitary preparations, medical supplies, personal care products, and healthcare products; promoting the sale of goods and services of others through electronic couponing, promotions and discounts; medical claims management services, namely, electronic audits of physician, hospital, and ancillary medical care provider transactions for purposes of providing consumers with affordable care options via the global information network; providing information on the topic of promoting patient, physician and employee satisfaction via a global computer network; retail pharmacy services; providing online consumer product information for the purpose of selection of pharmaceuticals, medications, diagnostic tests, and other medical productsACTIVE
036Pharmacy benefit management services; providing a website featuring health care administration, namely, administration of pre-paid health care plans; providing a website featuring information in the field of claims administration in the field of health care; providing a website featuring information in the field of health care administration, namely, administration of pre-paid health care plans health care administrationACTIVE
042Design and development of computer hardware and software for use in the fields of medicine, medical care, health care, health, wellness, diagnostics, laboratory testing, virtual health care, pharmaceutical prescription services, and health care administration; software as a service (SaaS) featuring software for providing consumer product information for the purpose of selection of pharmaceuticals and over the counter medications; software as a service (SaaS) featuring software for prescription ordering, fulfillment, delivery, and management; software as a service (SaaS) featuring software that provides retail and ordering services for pharmaceutical preparations, sanitary preparations, medical supplies, personal care products, and healthcare products; software as a service (SaaS) featuring software for training and education in the fields of medicine, medical care, health care, health, wellness, diagnostics, laboratory testing, virtual health care, pharmaceutical prescription services, and health care administration; providing online non-downloadable software for administering at-home tests; software as a service (SaaS) featuring software to permit users to identify, request, and receive pharmacy products; providing online non-downloadable software to permit users to identify, request, and receive pharmacy products; providing online non-downloadable software for providing consumer product information for the purpose of selection of pharmaceuticals and over the counter medications; providing online non-downloadable software for prescription ordering, fulfillment, delivery, and management; providing online non-downloadable software that provides retail and ordering services for pharmaceutical preparations, sanitary preparations, medical supplies, personal care products, and healthcare products; providing a website featuring information on the technology used to create medical devices, medical diagnostic tests and drugs; providing a web site featuring technology that enables physicians to generate, manage, and exchange medical information and documents; scientific research and development of vaccines, pharmaceutical preparations, diagnostic tests, and medicinesACTIVE
044Services relating to the dispensing of medications, namely, preparation and dispensing of medications; preparation of prescriptions by pharmacists; prescription reminder refill services; chiropractic services; acupuncture services; providing a website featuring information in the field pharmaceutical prescription services, namely, preparation of prescription in pharmaciesACTIVE
045Providing information about legal eligibility requirements for government medical and pharmaceutical programsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2026EX4GSOU EXTENSION 4 GRANTED
Aug 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 13, 2026EXT4SOU EXTENSION 4 FILED
Feb 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 24, 2026EX3GSOU EXTENSION 3 GRANTED
Feb 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 22, 2026EXT3SOU EXTENSION 3 FILED
Jan 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2026NOACCORRECTED NOA E-MAILED
Jan 27, 2026EX2GSOU EXTENSION 2 GRANTED
Jan 27, 2026DPCCDIVISIONAL PROCESSING COMPLETE
Jan 24, 2026DOCKASSIGNED TO EXAMINER
Jan 23, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 2, 2025EXT2SOU EXTENSION 2 FILED
Jul 14, 2025DRRRDIVISIONAL REQUEST RECEIVED
Jul 14, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED
Mar 6, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2025EX1GSOU EXTENSION 1 GRANTED
Mar 5, 2025EXT1SOU EXTENSION 1 FILED
Mar 5, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2024XAECEXAMINER'S AMENDMENT ENTERED
Jun 10, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Jun 10, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 10, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 7, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
May 7, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 22, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2024XAECEXAMINER'S AMENDMENT ENTERED
Apr 22, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 22, 2024GNEAEXAMINERS AMENDMENT E-MAILED
Apr 22, 2024CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 17, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 20, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 20, 2023GNSLLETTER OF SUSPENSION E-MAILED
Aug 20, 2023CNSLSUSPENSION LETTER WRITTEN
Jul 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 26, 2023DOCKASSIGNED TO EXAMINER
Aug 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance